ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,748Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 336

$565K Total Retail Price of All Prescriptions

Rank: 130 out of 336

621 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 621 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 621 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 10,359 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 535 313 S3 1 2
OMEPRAZOLE 488 396 2 3
FUROSEMIDE 436 365 3 4
AMLODIPINE BESYLATE 417 365 4 1
LEVOTHYROXINE SODIUM 359 300 5 7
SIMVASTATIN 311 265 6 5
PRAVASTATIN SODIUM 295 272 7 10
ATENOLOL 285 235 8 26
LISINOPRIL 280 251 9 6
PREDNISONE 272 238 10 48
ZOLPIDEM TARTRATE 239 182 11 18
METOPROLOL SUCCINATE 233 214 12 15
POTASSIUM CHLORIDE 206 161 13 9
METFORMIN HCL 204 167 14 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 198 179 15 23
METOPROLOL TARTRATE 175 127 16 16
DONEPEZIL HCL 164 164 17 27
CITALOPRAM HBR 161 137 18 21
HYDROCHLOROTHIAZIDE 158 116 19 12
CIPROFLOXACIN HCL 150 123 20 55
WARFARIN SODIUM 148 123 21 17
SYNTHROID 141 129 22 43
CEFDINIR 136 112 23 216
LOVASTATIN 130 113 24 34
ATORVASTATIN CALCIUM 125 109 25 14
NEXIUM 120 82 26 24
DIOVAN 119 119 27 31
GABAPENTIN 119 104 27 11
GLYBURIDE-METFORMIN HCL 115 107 R 29 78
TAMSULOSIN HCL 114 103 30 38
KLOR-CON M20 112 90 31 51
CARVEDILOL 102 92 32 13
NAMENDA 101 101 33 39
MELOXICAM 100 86 34 19
NABUMETONE 100 75 34 159
ALLOPURINOL 97 93 36 30
FLUTICASONE PROPIONATE 96 79 37 49
CLONIDINE HCL 96 69 37 32
TRAMADOL HCL 95 74 39 20
SERTRALINE HCL 89 85 40 33
CYCLOBENZAPRINE HCL 88 37 R 41 65
PANTOPRAZOLE SODIUM 86 77 42 40
HUMULIN 70-30 76 61 43 173
PLAVIX 74 66 44 37
KLOR-CON 10 73 63 45 75
LIPITOR 68 53 46 62
TRIAMTERENE-HCTZ 66 57 47 35
SINGULAIR 65 50 48 85
CLOPIDOGREL 65 53 48 28
DIOVAN HCT 64 50 50 41
ALENDRONATE SODIUM 64 64 50 54
CYMBALTA 60 39 52 52
GLYBURIDE 57 40 R 53 76
LOSARTAN POTASSIUM 54 43 54 22
CARISOPRODOL 54 0 R 54 63
POLYETHYLENE GLYCOL 3350 53 52 56 68
PROPRANOLOL HCL 51 50 57 101
TRAZODONE HCL 51 24 57 46
GLIMEPIRIDE 50 48 59 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.